These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 334211)

  • 41. Antihypertensive effects of sotalol and atenolol given once daily.
    Leary WP; Asmal AC; Brayshaw P; Williams P
    S Afr Med J; 1980 Apr; 57(17):692-5. PubMed ID: 6996120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dose-response study of atenolol in mild to moderate hypertension in general practice.
    Gostick NK; Mayhew SR; Million R; Sagar D; Suxena SR; Ingram DF; Barmer NP
    Curr Med Res Opin; 1977; 5(2):179-84. PubMed ID: 340136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
    Webster J; Jeffers TA; Galloway DB; Petrie JC; Barker NP
    Br Med J; 1977 Jan; 1(6053):76-8. PubMed ID: 12850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Once-daily atenolol in hypertensive Zimbabwean blacks. A double-blind trial using two different doses.
    Abson CP; Levy LM; Eyherabide G
    S Afr Med J; 1981 Jul; 60(2):47-8. PubMed ID: 7017966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of once daily tenormin (atenolol) in hypertension: some implications in patient compliance.
    Harris AM; Wollard KV; Tweed JA
    J Int Med Res; 1976; 4(5):347-51. PubMed ID: 1028635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD
    Aust N Z J Med; 1981 Feb; 11(1):35-40. PubMed ID: 7018482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernandez-Pieretti O
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():363s-365s. PubMed ID: 396082
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
    Erina EV; Charyev KhE; Oshchepkova EV
    Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.
    Marshall AJ; Barritt DW; Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():168-72. PubMed ID: 337271
    [No Abstract]   [Full Text] [Related]  

  • 52. Atenolol in hypertension: a cardioselective drug.
    Ezra D; Molho M; Rosenthal T
    Chest; 1980 May; 77(5):662-5. PubMed ID: 7363686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of atenolol in hypertension.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Henningsen NC; Jameson S
    Clin Sci Mol Med Suppl; 1976 Dec; 3():513s-515s. PubMed ID: 799559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of the effects of lisinopril when used in addition to atenolol.
    Soininen K; Gerlin-Piira L; Suihkonen J; Kyllönen T; Parviainen R; Kyllönen E; Hämäläinen K; Lonka R; Tikkanen T; Selonen R
    J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative trial of atenolol and propranolol in hyperthyroidism.
    McDevitt DG; Nelson JK
    Br J Clin Pharmacol; 1978 Sep; 6(3):233-7. PubMed ID: 356867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
    Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
    Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
    Houtzagers JJ; Chadha DR
    J Int Med Res; 1982; 10(1):1-5. PubMed ID: 7060821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of propranolol and atenolol in hypertension.
    Zacharias FJ; Cowen KJ
    Postgrad Med J; 1977; 53 Suppl 3():111-3. PubMed ID: 337264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.